Be A Freedom Fighter · Bill Library
HR 10924 — Medicare for America Act of 2026
Freedom score: -6 (scale −10 to +10)
- Individual rights: -1
- Property rights: -2
- Economic freedom: -2
- Privacy & due process: +1
- Government power: -2
Sponsor: Rep. DeLauro, Rosa L. [D-CT-3] · Latest action: Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, the Judiciary, Natural Resources, Education and Workforce, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2026-10-29)
Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index
Findings — 41 highlighted provisions
Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.
- Sec. 103(a)(4), Sec. 103(b) · Individual Rights — Transitional public option covers reproductive health including abortion; state prohibitions on that coverage preempted See in text ↓
- Sec. 105(b)(3) · Individual Rights — Participating providers cannot deny covered services based on religious objections See in text ↓
- Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services See in text ↓
- Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension See in text ↓
- Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation See in text ↓
- Sec. 203 · Property Rights — Inherited-property basis modified See in text ↓
- Sec. 304(a) · Property Rights — Drug/device patent terms may be shortened by up to five years for excessive pricing See in text ↓
- Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding See in text ↓
- Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity See in text ↓
- Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment See in text ↓
- Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration See in text ↓
- Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs See in text ↓
- Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity See in text ↓
- Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation See in text ↓
- Sec. 131 · Economic Freedom — Pediatric medical necessity and biennial review See in text ↓
- Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year See in text ↓
- Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal See in text ↓
- Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise See in text ↓
- Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028 See in text ↓
- Sec. 309 · Economic Freedom — Drug advertising restrictions See in text ↓
- Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty See in text ↓
- Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers See in text ↓
- Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings See in text ↓
- Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality See in text ↓
- Sec. 303(c)–(d) · Privacy and Due Process — Notice, correction and 90-day decision on excessive-price petitions See in text ↓
- Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards See in text ↓
- Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection See in text ↓
- Sec. 402(a)–(c) · Privacy and Due Process — De-identified administrative-data analysis within two years, longitudinal study and decennial health-outcomes reports See in text ↓
- Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund See in text ↓
- Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking See in text ↓
- Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes See in text ↓
- Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules See in text ↓
- Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions See in text ↓
- Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions See in text ↓
- Sec. 306 · Government Power — Board notice-and-comment regulations within one year after first meeting See in text ↓
- Sec. 307 · Government Power — Annual public excessive-price reports to federal agencies See in text ↓
- Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost See in text ↓
- Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports See in text ↓
- Sec. 401 · Government Power — Nonoperative sense of Congress See in text ↓
- Sec. 402 · Government Power — evaluation, de-identified research and recurring reports See in text ↓
- Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score See in text ↓
Full text (introduced version)
604 of 606 text blocks highlighted. Source: GovInfo, fetched cached.
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
SEC. 101. ESTABLISHMENT.
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 102. ELIGIBILITY.
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 103. BENEFITS.
Sec. 103(a)(4), Sec. 103(b) · Individual Rights — Transitional public option covers reproductive health including abortion; state prohibitions on that coverage preempted
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 103(a)(4), Sec. 103(b) · Individual Rights — Transitional public option covers reproductive health including abortion; state prohibitions on that coverage preempted
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 103(a)(4), Sec. 103(b) · Individual Rights — Transitional public option covers reproductive health including abortion; state prohibitions on that coverage preempted
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 103(a)(4), Sec. 103(b) · Individual Rights — Transitional public option covers reproductive health including abortion; state prohibitions on that coverage preempted
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 103(a)(4), Sec. 103(b) · Individual Rights — Transitional public option covers reproductive health including abortion; state prohibitions on that coverage preempted
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 104. PREMIUMS.
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 105. PROVIDERS AND REIMBURSEMENT RATES.
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 105(b)(3) · Individual Rights — Participating providers cannot deny covered services based on religious objections
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 105(b)(3) · Individual Rights — Participating providers cannot deny covered services based on religious objections
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 106. ACCOUNT; FUNDING.
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 101–106 · Economic Freedom — Transitional 2028–2029 public option, Exchange eligibility, required benefits, income-related premiums, provider payments and Treasury funding
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 111. ESTABLISHMENT AND ADMINISTRATION OF MEDICARE FOR AMERICA.
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 111, new SSA §2203(f) · Individual Rights — Prior authorization and step therapy barred for covered program services
Sec. 111, new SSA §2206 · Property Rights — Competitive licensing of drug patents, trial data and exclusivity if price negotiations fail, with Secretary-determined compensation
Sec. 111, new SSA §§2201–2202 · Economic Freedom — Establish program, resident/lawfully-present eligibility, HHS eligibility rules, 2028 enrollment mechanisms and automatic enrollment (some dual eligibles 2030); card identifier cannot be SSN. Note §2201 refers to 2026 benefits, creating timing ambiguity
Sec. 111, new SSA §§2203–2205 · Economic Freedom — Comprehensive health, dental, vision and long-term benefits; no prior authorization; payment at 80% generally and 100% for specified categories; no deductible; out-of-pocket ceilings $3,500 individual/$5,000 household and CPI adjustment
Sec. 111, new SSA §§2206–2209 · Economic Freedom — Drug negotiation, trust fund, appeals, state maintenance-of-effort and administration
Sec. 111, new SSA §§2231–2232 · Economic Freedom — Home/community long-term supports based on substantial assistance with daily living or functional needs; eligibility continuity for fluctuating needs
Sec. 111, new SSA §2202(b) · Privacy and Due Process — Enrollment identification cards cannot use Social Security numbers
Sec. 111, new SSA §2208(c)–(d) · Privacy and Due Process — Administrative appeals and coverage hearings
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 112. MODIFICATIONS TO AND COORDINATION WITH EXISTING FEDERAL HEALTH PROGRAMS.
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 112; Secs. 121–129 · Economic Freedom — Coordinate existing programs; Medicare Advantage network changes, provider adequacy, disability waiting period, Medicaid waiting-list coverage, employer options, utilization restrictions, observation services, abortion coverage and parity
Sec. 101–112 · Government Power — Establish public option and permanent health-financing apparatus; HHS eligibility and payment rules, federal trust fund
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 121. LIMITATION ON REMOVAL OF MEDICARE ADVANTAGE PROVIDERS BY MA ORGANIZATIONS.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 122. NETWORK ADEQUACY.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 123. ELIMINATING THE 24-MONTH WAITING PERIOD FOR MEDICARE COVERAGE FOR INDIVIDUALS WITH DISABILITIES.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 124. ELIMINATING THE WAITING PERIOD FOR INDIVIDUALS ON STATE MEDICAID WAITING LISTS.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 125. EMPLOYER HEALTH PLAN OPTIONS.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 126. PROHIBITION ON STEP THERAPY AND PRIOR AUTHORIZATION UNDER GROUP HEALTH PLANS.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 127. MEDICARE OUTPATIENT OBSERVATION SERVICES.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 128. ABORTION COVERAGE.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 129. APPLICABILITY OF MENTAL HEALTH PARITY.
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 130. STUDENT LOAN FORGIVENESS FOR HEALTH CARE PROVIDERS PARTICIPATING IN MEDICARE FOR AMERICA.
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 130 · Economic Freedom — Qualifying health-provider student-loan forgiveness, certifications, deferment and interest cancellation
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 131. CLARIFICATION OF THE DEFINITION OF PEDIATRIC MEDICAL NECESSITY IN QUALIFYING GROUP COVERAGE.
Sec. 131 · Economic Freedom — Pediatric medical necessity and biennial review
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 131 · Economic Freedom — Pediatric medical necessity and biennial review
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 131 · Economic Freedom — Pediatric medical necessity and biennial review
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 131 · Economic Freedom — Pediatric medical necessity and biennial review
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 131 · Economic Freedom — Pediatric medical necessity and biennial review
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 131 · Economic Freedom — Pediatric medical necessity and biennial review
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 132. SAFE STAFFING REQUIREMENTS.
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 132 · Economic Freedom — Nurse staffing mandates, Medicare/Medicaid conditions and nursing-home standards within one year
Sec. 132, new PHSA §§3404, Sec. 3407 · Privacy and Due Process — Nurse safety-assignment refusal and anti-retaliation, patient confidentiality
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 133. ENHANCEMENTS FOR REDUCED COST-SHARING.
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 134. REPEAL OF BONUS PAYMENTS FOR MEDICARE ADVANTAGE PLANS.
Sec. 133–134 · Economic Freedom — Cost-sharing assistance changes and Medicare Advantage bonus-payment repeal
Sec. 121–134 · Government Power — Federal coverage, insurer and staffing mandates; nursing-home rulemaking
Sec. 101–134 · Government Power — 201–210, 301–310 and 401–402 establish health coverage, insurance/provider mandates, taxes, drug-price controls, patent remedies, appeals and research. Subsection audit not certified exhaustive; DRAFT — publication HOLD pending further audit. Cato qualification: ON-POINT for general Medicare/health-financing mechanisms, not a review of this exact bill; did not change any score
SEC. 201. SUNSET OF PUBLIC LAWS 115-97 AND 119-21.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 202. SURTAX.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 203. BASIS OF PROPERTY ACQUIRED FROM A DECEDENT.
Sec. 203 · Property Rights — Inherited-property basis modified
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 203 · Property Rights — Inherited-property basis modified
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 204. MEDICARE PAYROLL TAX.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 205. NET INVESTMENT INCOME TAX.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 206. TERMINATION OF DEDUCTION FOR CONTRIBUTIONS TO HEALTH SAVINGS ACCOUNTS.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 207. INCREASE IN EXCISE TAX ON SMALL CIGARS AND CIGARETTES AND OTHER TOBACCO PRODUCTS.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 208. EXCISE TAX ON ALCOHOL.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 209. TAX ON SUGARED DRINKS.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 210. REPEAL OF EXCISE TAX ON HIGH-COST EMPLOYER-SPONSORED HEALTH COVERAGE.
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
Sec. 201–210 · Economic Freedom — Tax overhaul: post-2027 reversal of PL115-97/PL119-21 changes; 5% surtax above $500k AGI; inherited basis; 4% additional Medicare tax; 6.9% net investment tax; zero HSA deduction limit after 2023; tobacco/alcohol excises; sugar beverage tax 1 cent/4.2g sweetener; repeal high-cost employer coverage excise
Sec. 201–210 · Government Power — IRS tax-base, rate, excise and effective-date changes
SEC. 301. ESTABLISHMENT OF THE PRESCRIPTION DRUG AND MEDICAL DEVICE REVIEW BOARD.
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
SEC. 302. MEMBERSHIP; STAFF.
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 301–302 · Government Power — Establish Prescription Drug and Medical Device Price Review Board, members, staff and conflict rules
SEC. 303. PROHIBITION AGAINST EXCESSIVE PRICE.
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303(c)–(d) · Privacy and Due Process — Notice, correction and 90-day decision on excessive-price petitions
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303(c)–(d) · Privacy and Due Process — Notice, correction and 90-day decision on excessive-price petitions
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303(c)–(d) · Privacy and Due Process — Notice, correction and 90-day decision on excessive-price petitions
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303(c)–(d) · Privacy and Due Process — Notice, correction and 90-day decision on excessive-price petitions
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303(c)–(d) · Privacy and Due Process — Notice, correction and 90-day decision on excessive-price petitions
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303(c)–(d) · Privacy and Due Process — Notice, correction and 90-day decision on excessive-price petitions
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
SEC. 304. ENFORCEMENT PROVISIONS.
Sec. 304(a) · Property Rights — Drug/device patent terms may be shortened by up to five years for excessive pricing
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 304(a) · Property Rights — Drug/device patent terms may be shortened by up to five years for excessive pricing
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 304(a) · Property Rights — Drug/device patent terms may be shortened by up to five years for excessive pricing
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
Sec. 301–304 · Economic Freedom — Price-review Board, manufacturer excessive-price formula, notice/correction, petition and sanctions including up to 10% gross sales and new excise tax on above-reasonable-price sales after 2028
Sec. 303–304 · Government Power — Price determination and civil, patent and tax sanctions
SEC. 305. AUTHORITY.
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
Sec. 305(e)–(g) · Privacy and Due Process — Board investigations and nationwide subpoenas; district-court enforcement and confidentiality safeguards
Sec. 305(a)–(g) · Government Power — Board interagency access, contracts, investigations, subpoenas and confidential-information restrictions
SEC. 306. REGULATIONS.
Sec. 306 · Government Power — Board notice-and-comment regulations within one year after first meeting
Sec. 306 · Government Power — Board notice-and-comment regulations within one year after first meeting
SEC. 307. REPORT TO FEDERAL AGENCIES.
Sec. 307 · Government Power — Annual public excessive-price reports to federal agencies
SEC. 308. DEFINITIONS.
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
Sec. 308 · Government Power — Definitions of affiliates, manufacturers, drugs, devices and wholesale acquisition cost
SEC. 309. MORATORIUM ON DIRECT-TO-CONSUMER DRUG ADVERTISING.
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 309, new FDCA §506J · Individual Rights — Restrict direct-to-consumer drug advertising initially for three years, with limited waiver and possible extension
Sec. 309 · Economic Freedom — Drug advertising restrictions
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
SEC. 310. REPORTING ON JUSTIFICATION FOR DRUG PRICE INCREASES.
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
Sec. 310 · Economic Freedom — Manufacturer advance reports of price rises at least 10%/12 months or 25%/36 months for qualifying drugs, with exemptions and $100k/day reporting penalty
Sec. 310 · Privacy and Due Process — Public manufacturer reports with trade-secret protection
Sec. 309–310 · Government Power — Drug-advertising regulation within one year and manufacturer price reports
SEC. 401. SENSE OF CONGRESS.
Sec. 401 · Government Power — Nonoperative sense of Congress
SEC. 402. EVALUATION OF BILL'S OUTCOME.
Sec. 402(a)–(c) · Privacy and Due Process — De-identified administrative-data analysis within two years, longitudinal study and decennial health-outcomes reports
Sec. 402 · Government Power — evaluation, de-identified research and recurring reports
Sec. 402(a)–(c) · Privacy and Due Process — De-identified administrative-data analysis within two years, longitudinal study and decennial health-outcomes reports
Sec. 402 · Government Power — evaluation, de-identified research and recurring reports
Sec. 402(a)–(c) · Privacy and Due Process — De-identified administrative-data analysis within two years, longitudinal study and decennial health-outcomes reports
Sec. 402 · Government Power — evaluation, de-identified research and recurring reports
Sec. 402(a)–(c) · Privacy and Due Process — De-identified administrative-data analysis within two years, longitudinal study and decennial health-outcomes reports
Sec. 402 · Government Power — evaluation, de-identified research and recurring reports
Sec. 402(a)–(c) · Privacy and Due Process — De-identified administrative-data analysis within two years, longitudinal study and decennial health-outcomes reports
Sec. 402 · Government Power — evaluation, de-identified research and recurring reports
Sec. 402(a)–(c) · Privacy and Due Process — De-identified administrative-data analysis within two years, longitudinal study and decennial health-outcomes reports
Sec. 402 · Government Power — evaluation, de-identified research and recurring reports
Findings source: bill-scores-v2-batch25-findings-2026-11-14.md. Highlights come only from that file; no finding, score, or provision was invented for this page.
What you can do
Contact your U.S. Representative and Senators about this bill.
Find your Representative Contact your Senators
Spot an error on this page? Report it.